ICE T for Post GYN Surgery Pain

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this randomized controlled trial is to determine whether, "ICE-T," a multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and tylenol, has improved pain control compared to the standard narcotic based postoperative pain regimen in patients undergoing total laparoscopic gyn surgery.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02773316` - Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution	Phase 1
	Enrolling by invitation	`NCT03390829` - Content and Expectations of Consultations of Patients With Opioid Substitution Treatment Considered as Stabilized: Cross-Testimonials Doctors - Patients (MSOSuiStab)	N/A

NCT number	NCT03987022
Study type	Interventional
Source	MetroHealth Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	August 1, 2019
Completion date	April 25, 2022

ICE T for Post GYN Surgery Pain

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms